At a Glance
| Methylnaphthidate | 3-FA | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 15–30 mg | 30–50 mg |
| Total Duration | 1.5–2.2 hrs | 2.8–5 hrs |
| Routes | insufflatedoral | oral |
Methylnaphthidate, a Stimulants, and 3-FA, a Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulantss, meaning they share a common pharmacological foundation. They share 9 documented effects in common, with 20 effects unique to Methylnaphthidate and 3 unique to 3-FA. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Methylnaphthidate | 3-FA | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 15–30 mg | 30–50 mg |
| Total Duration | 1.5–2.2 hrs | 2.8–5 hrs |
| Routes | insufflatedoral | oral |
| Effects | 29 documented | 12 documented |
| Level | Methylnaphthidate | 3-FA |
|---|---|---|
| Threshold | 4 mg | 10 mg |
| Light | 10–15 mg | 20–30 mg |
| Common | 15–30 mg | 30–50 mg |
| Strong | 30–50 mg | 50–70 mg |
| Heavy | 50 mg | 70 mg |
| Level | Dose |
|---|---|
| Light | 4–8 mg |
| Common | 8–14 mg |
| Strong | 14–28 mg |
| Heavy | 28 mg |
Methylnaphthidate
3-FA
No direct interaction data available between these substances. This does not mean the combination is safe.